Capstone Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AL
Capstone Asset Management's DGX Position: Q2 2017 in Review
Capstone Asset Management increased its Quest Diagnostics (DGX) stake by 0.63% in Q2 2017, buying an estimated $78.7K and bringing the position to 119,657 shares worth $13.3M. The position accounts for 0.37% of the portfolio, ranked #54.
Capstone Asset Management first reported a position in DGX in Q2 2013 and has held it in 17 quarters since. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.
- Capstone Asset Management held 119,657 shares of Quest Diagnostics worth $13.3M as of Q2 2017.
- Capstone Asset Management bought 744 Quest Diagnostics shares in Q2 2017, an estimated $78.7K.
- Quest Diagnostics made up 0.37% of Capstone Asset Management's portfolio in Q2 2017, its #54 holding.
- Capstone Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 17 quarters since.
- 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.